HEADER VIRAL PROTEIN 17-JUN-22 8DCQ TITLE CRYSTAL STRUCTURE OF HIV-1 LM/HT CLADE A/E CRF01 GP120 CORE IN COMPLEX TITLE 2 WITH YIR-821 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 LM/HT CLADE A/E CRF01 GP120 CORE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: HIV-1 ENV; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL: HEK 293 GNT1-; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS HIV-1 GP120, CLADE A/E CF01, VIRAL PROTEIN, VIRAL PROTEIN-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.D.TOLBERT,M.PAZGIER REVDAT 3 25-OCT-23 8DCQ 1 REMARK REVDAT 2 08-FEB-23 8DCQ 1 JRNL REVDAT 1 11-JAN-23 8DCQ 0 JRNL AUTH K.MATSUMOTO,T.KUWATA,W.D.TOLBERT,J.RICHARD,S.DING,J.PREVOST, JRNL AUTH 2 S.TAKAHAMA,G.P.JUDICATE,T.UENO,H.NAKATA,T.KOBAYAKAWA, JRNL AUTH 3 K.TSUJI,H.TAMAMURA,A.B.SMITH 3RD,M.PAZGIER,A.FINZI, JRNL AUTH 4 S.MATSUSHITA JRNL TITL CHARACTERIZATION OF A NOVEL CD4 MIMETIC COMPOUND YIR-821 JRNL TITL 2 AGAINST HIV-1 CLINICAL ISOLATES. JRNL REF J.VIROL. V. 97 63822 2023 JRNL REFN ESSN 1098-5514 JRNL PMID 36511698 JRNL DOI 10.1128/JVI.01638-22 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.69 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.080 REMARK 3 COMPLETENESS FOR RANGE (%) : 65.5 REMARK 3 NUMBER OF REFLECTIONS : 8078 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 398 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.6900 - 4.6200 0.63 2493 111 0.1977 0.2312 REMARK 3 2 4.6100 - 3.6600 0.66 2575 124 0.2113 0.2884 REMARK 3 3 3.6600 - 3.2000 0.67 2612 163 0.2713 0.3131 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2935 REMARK 3 ANGLE : 1.094 3981 REMARK 3 CHIRALITY : 0.105 465 REMARK 3 PLANARITY : 0.008 492 REMARK 3 DIHEDRAL : 21.031 456 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DCQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1000266448. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8078 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 72.3 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.27600 REMARK 200 FOR THE DATA SET : 2.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6ONF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 1500 5% PEG 400 0.1 M HEPES PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.83000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.69000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.64000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.69000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.83000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.64000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 42 REMARK 465 LYS A 194 REMARK 465 LEU A 195 REMARK 465 THR A 196 REMARK 465 GLY A 197 REMARK 465 GLY A 198 REMARK 465 SER A 199 REMARK 465 ASN A 317 REMARK 465 GLY A 318 REMARK 465 GLY A 319 REMARK 465 SER A 320 REMARK 465 GLY A 321 REMARK 465 SER A 322 REMARK 465 GLY A 323 REMARK 465 GLY A 324 REMARK 465 GLY A 403 REMARK 465 ASN A 404 REMARK 465 GLU A 405 REMARK 465 THR A 406 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 44 114.97 54.16 REMARK 500 GLU A 64 51.62 -60.61 REMARK 500 VAL A 65 -41.96 24.84 REMARK 500 ASN A 94 113.98 -164.96 REMARK 500 SER A 115 -94.47 -80.22 REMARK 500 CYS A 205 70.65 -115.13 REMARK 500 ASP A 211 107.15 -165.91 REMARK 500 PRO A 220 -130.09 -77.62 REMARK 500 ASN A 232 -94.66 -94.77 REMARK 500 PHE A 233 117.17 68.54 REMARK 500 CYS A 239 -140.29 -96.17 REMARK 500 LYS A 240 -34.69 174.26 REMARK 500 ASN A 241 74.34 -116.90 REMARK 500 THR A 248 -116.79 -64.94 REMARK 500 GLN A 258 -46.10 63.10 REMARK 500 GLU A 268 -101.86 -125.69 REMARK 500 PRO A 299 -146.71 -95.42 REMARK 500 ASN A 354 85.66 63.62 REMARK 500 ASN A 355 63.96 11.41 REMARK 500 HIS A 374 93.50 -53.10 REMARK 500 THR A 387 72.15 -59.77 REMARK 500 PHE A 391 73.87 -111.91 REMARK 500 ASN A 411 84.04 -171.90 REMARK 500 THR A 430 86.05 52.28 REMARK 500 TYR A 435 -140.39 -112.12 REMARK 500 THR A 450 -34.43 -141.05 REMARK 500 ALA A 460 34.33 -157.41 REMARK 500 LEU A 483 42.60 -96.61 REMARK 500 REMARK 500 REMARK: NULL DBREF1 8DCQ A 44 492 UNP A0A0M3KKW9_9HIV1 DBREF2 8DCQ A A0A0M3KKW9 1 353 SEQADV 8DCQ VAL A 42 UNP A0A0M3KKW EXPRESSION TAG SEQADV 8DCQ PRO A 43 UNP A0A0M3KKW EXPRESSION TAG SEQADV 8DCQ TYR A 61 UNP A0A0M3KKW HIS 18 ENGINEERED MUTATION SEQADV 8DCQ HIS A 105 UNP A0A0M3KKW GLN 62 ENGINEERED MUTATION SEQADV 8DCQ ILE A 108 UNP A0A0M3KKW VAL 65 ENGINEERED MUTATION SEQADV 8DCQ THR A 375 UNP A0A0M3KKW HIS 242 ENGINEERED MUTATION SEQADV 8DCQ ASP A 474 UNP A0A0M3KKW ASN 335 ENGINEERED MUTATION SEQADV 8DCQ MET A 475 UNP A0A0M3KKW ILE 336 ENGINEERED MUTATION SEQADV 8DCQ ARG A 476 UNP A0A0M3KKW LYS 337 ENGINEERED MUTATION SEQRES 1 A 355 VAL PRO VAL TRP LYS ASP ALA ASP THR THR LEU PHE CYS SEQRES 2 A 355 ALA SER ASP ALA LYS ALA TYR GLU THR GLU VAL HIS ASN SEQRES 3 A 355 VAL TRP ALA THR HIS ALA CYS VAL PRO THR ASP PRO ASN SEQRES 4 A 355 PRO GLN GLU ILE HIS LEU GLU ASN VAL THR GLU ASN PHE SEQRES 5 A 355 ASN MET TRP LYS ASN ASN MET VAL GLU GLN MET HIS GLU SEQRES 6 A 355 ASP ILE ILE SER LEU TRP ASP GLN SER LEU GLN PRO CYS SEQRES 7 A 355 VAL LYS LEU THR GLY GLY SER VAL ILE LYS GLN ALA CYS SEQRES 8 A 355 PRO LYS ILE SER PHE ASP PRO ILE PRO ILE HIS TYR CYS SEQRES 9 A 355 THR PRO ALA GLY TYR VAL ILE LEU LYS CYS ASN ASP LYS SEQRES 10 A 355 ASN PHE ASN GLY THR GLY PRO CYS LYS ASN VAL SER SER SEQRES 11 A 355 VAL GLN CYS THR HIS GLY ILE LYS PRO VAL VAL SER THR SEQRES 12 A 355 GLN LEU LEU LEU ASN GLY SER LEU ALA GLU GLU GLU ILE SEQRES 13 A 355 ILE ILE ARG SER GLU ASN LEU THR ASN ASN ALA LYS THR SEQRES 14 A 355 ILE ILE VAL HIS LEU ASN LYS SER VAL GLU ILE ASN CYS SEQRES 15 A 355 THR ARG PRO SER ASN GLY GLY SER GLY SER GLY GLY ASP SEQRES 16 A 355 ILE ARG LYS ALA TYR CYS GLU ILE ASN GLY THR LYS TRP SEQRES 17 A 355 ASN LYS VAL LEU LYS GLN VAL THR GLU LYS LEU LYS GLU SEQRES 18 A 355 HIS PHE ASN ASN LYS THR ILE ILE PHE GLN PRO PRO SER SEQRES 19 A 355 GLY GLY ASP LEU GLU ILE THR MET HIS THR PHE ASN CYS SEQRES 20 A 355 ARG GLY GLU PHE PHE TYR CYS ASN THR THR GLN LEU PHE SEQRES 21 A 355 ASN ASN THR CYS ILE GLY ASN GLU THR MET LYS GLY CYS SEQRES 22 A 355 ASN GLY THR ILE THR LEU PRO CYS LYS ILE LYS GLN ILE SEQRES 23 A 355 ILE ASN MET TRP GLN GLY THR GLY GLN ALA MET TYR ALA SEQRES 24 A 355 PRO PRO ILE ASP GLY LYS ILE ASN CYS VAL SER ASN ILE SEQRES 25 A 355 THR GLY ILE LEU LEU THR ARG ASP GLY GLY ALA ASN ASN SEQRES 26 A 355 THR SER ASN GLU THR PHE ARG PRO GLY GLY GLY ASP MET SEQRES 27 A 355 ARG ASP ASN TRP ARG SER GLU LEU TYR LYS TYR LYS VAL SEQRES 28 A 355 VAL GLN ILE GLU HET NAG A 501 14 HET NAG A 502 14 HET NAG A 503 14 HET NAG A 504 14 HET NAG A 505 14 HET NAG A 506 14 HET NAG A 507 14 HET NAG A 508 14 HET NAG A 509 14 HET NAG A 510 14 HET R5K A 511 74 HET EPE A 512 15 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM R5K N~1~-{(3R)-1-[2-(5-CARBAMIMIDAMIDOPENTANAMIDO)ETHYL]-1- HETNAM 2 R5K AZASPIRO[5.5]UNDECAN-3-YL}-N~2~-(4-CHLOROPHENYL) HETNAM 3 R5K ETHANEDIAMIDE HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN EPE HEPES FORMUL 2 NAG 10(C8 H15 N O6) FORMUL 12 R5K C26 H40 CL N7 O3 FORMUL 13 EPE C8 H18 N2 O4 S HELIX 1 AA1 VAL A 65 THR A 71 1 7 HELIX 2 AA2 ASN A 98 SER A 115 1 18 HELIX 3 AA3 ASN A 334 PHE A 353 1 20 HELIX 4 AA4 ASP A 368 MET A 373 1 6 HELIX 5 AA5 MET A 475 SER A 481 1 7 SHEET 1 AA1 5 LYS A 46 ASP A 47 0 SHEET 2 AA1 5 TYR A 486 GLN A 490 -1 O GLN A 490 N LYS A 46 SHEET 3 AA1 5 TYR A 223 CYS A 228 -1 N LEU A 226 O LYS A 487 SHEET 4 AA1 5 VAL A 242 VAL A 245 -1 O SER A 243 N LYS A 227 SHEET 5 AA1 5 ILE A 84 HIS A 85 -1 N ILE A 84 O SER A 244 SHEET 1 AA2 2 PHE A 53 ALA A 55 0 SHEET 2 AA2 2 HIS A 216 CYS A 218 -1 O CYS A 218 N PHE A 53 SHEET 1 AA3 2 ASN A 92 PHE A 93 0 SHEET 2 AA3 2 GLY A 237 PRO A 238 -1 O GLY A 237 N PHE A 93 SHEET 1 AA4 4 LEU A 259 LEU A 261 0 SHEET 2 AA4 4 ILE A 443 LEU A 454 -1 O THR A 450 N LEU A 260 SHEET 3 AA4 4 ILE A 284 HIS A 287 -1 N ILE A 284 O LEU A 454 SHEET 4 AA4 4 ILE A 271 ARG A 273 -1 N ARG A 273 O ILE A 285 SHEET 1 AA5 7 LEU A 259 LEU A 261 0 SHEET 2 AA5 7 ILE A 443 LEU A 454 -1 O THR A 450 N LEU A 260 SHEET 3 AA5 7 VAL A 292 ARG A 298 -1 N ILE A 294 O SER A 447 SHEET 4 AA5 7 LYS A 328 ILE A 333 -1 O GLU A 332 N ASN A 295 SHEET 5 AA5 7 LEU A 416 ILE A 420 -1 O CYS A 418 N ALA A 329 SHEET 6 AA5 7 GLU A 381 CYS A 385 -1 N TYR A 384 O LYS A 419 SHEET 7 AA5 7 HIS A 374 CYS A 378 -1 N CYS A 378 O GLU A 381 SHEET 1 AA6 2 THR A 358 PHE A 361 0 SHEET 2 AA6 2 ASN A 465 PHE A 468 1 O PHE A 468 N ILE A 360 SHEET 1 AA7 2 ILE A 423 ASN A 425 0 SHEET 2 AA7 2 GLN A 432 MET A 434 -1 O ALA A 433 N ILE A 424 SSBOND 1 CYS A 54 CYS A 74 1555 1555 2.03 SSBOND 2 CYS A 119 CYS A 205 1555 1555 2.03 SSBOND 3 CYS A 218 CYS A 247 1555 1555 2.03 SSBOND 4 CYS A 228 CYS A 239 1555 1555 2.03 SSBOND 5 CYS A 296 CYS A 331 1555 1555 2.03 SSBOND 6 CYS A 378 CYS A 445 1555 1555 2.03 SSBOND 7 CYS A 385 CYS A 418 1555 1555 2.03 SSBOND 8 CYS A 395 CYS A 410 1555 1555 2.03 LINK ND2 ASN A 234 C1 NAG A 501 1555 1555 1.44 LINK ND2 ASN A 241 C1 NAG A 502 1555 1555 1.44 LINK ND2 ASN A 262 C1 NAG A 503 1555 1555 1.44 LINK ND2 ASN A 276 C1 NAG A 504 1555 1555 1.43 LINK ND2 ASN A 289 C1 NAG A 505 1555 1555 1.44 LINK ND2 ASN A 295 C1 NAG A 506 1555 1555 1.42 LINK ND2 ASN A 334 C1 NAG A 507 1555 1555 1.44 LINK ND2 ASN A 355 C1 NAG A 509 1555 1555 1.41 LINK ND2 ASN A 386 C1 NAG A 508 1555 1555 1.43 LINK ND2 ASN A 448 C1 NAG A 510 1555 1555 1.43 CRYST1 65.660 67.280 87.380 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015230 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014863 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011444 0.00000